Heat Biologics

Heat Biologics

Heat Biologics is a company that has developed a T-cell Activation Platform therapy designed identify oncology and infectious diseases

Heat Biologics is a company that has developed a T-cell Activation Platform therapy designed to identify oncology and infectious diseases. The company was founded in 2008 by Jeff Wolf, in Chapel Hill, North Carolina, United States.

Heat Biologics' T-cell Activation Platform can be administered with checkpoint inhibitors and other immuno-modulators.

COVID-19

With the outbreak of COVID-19 (coronavirus), the company has launched a program to develop a vaccine designed to protect against the virus. The company has created a platform called gp96 which has provided treatment and prevention options for the response or induction of mucosal immunity in SIV/HIV, malaria, zika, and other dangerous diseases. Heat Biologics has launched a program with its subsidiary, Zovolax, to use this gpp96 platform to create a vaccine against the SARS-CoV-2 which ultimately causes COVID-19.

The protein gp96 is found in all human cells and takes the responsibility of acting as a "molecular warning system" to induce immunity against necrotic cells. The company believes that this protein is a useful vaccine platform that has been proven to induce immune response and immunity in the case of several infectious disease models. They are working to make this protein platform a viable option against COVID-19 and any variant strand of the virus.

Timeline

May 21, 2012
Heat Biologics raises a $2,800,000 series A round.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Heat Biologics funding round, April 2013
5,050,050
April 9, 2013
2 Results
Results per page:
Page 1 of 1

Products

Product
Website
Industry
Launch date
HS-110
3 Results
Results per page:
Page 1 of 1

SBA Awards

SBA Award
Agency
Award Type
Amount (USD)
Date Awarded
Heat Biologics, Inc. SBIR Phase I Award,
SBIR
300,000
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Jeff Wolf

Founder, CEO

Matt Czajkowski

CFO

Sandra Silberman

CMO

Further reading

Title
Author
Link
Type
Date

Heat Biologics | Crunchbase

Web

Heat Biologics Launches Program to Develop Vaccine Designed to Protect Against COVID-19 Coronavirus

Web

March 3, 2020

Heat Biologics, Inc.

Web

March 5, 2020

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Heat Biologics

Jeff Wolf

Chapel Hill, North Carolina, United States

Biotechnology, vaccines

News

Title
Author
Date
Publisher
Description
FinancialBuzz.com
November 16, 2020
www.prnewswire.com:443
/PRNewswire/ -- New restrictions are being implemented in several states across the country as the number of those infected with COVID-19 is once again on the...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.